Dyne Therapeutics (DYN) Interest Coverage Ratio (2025)

Dyne Therapeutics (DYN) has reported Interest Coverage Ratio for 8 consecutive years, with 2.05 the latest figure, recorded in Q2 2026.

• In Q2 2026, Interest Coverage Ratio changed N/A year-over-year to 2.05; the TTM figure through Jun 2026 stood at 6.05 (up 92.88% YoY), while the FY2025 annual figure was 1.12, up 6.26% from the prior year.
• Interest Coverage Ratio climbed to 2.05 in Q2 2026 per DYN's latest filing, from 2.54 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.35 in Q4 2022 and bottomed at 45.61 in Q4 2025.
• Historically, Interest Coverage Ratio has averaged 8.97 across 5 years, with a median of 2.28 in 2023.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 99.86% — and 2024, when it plunged 4098.65%.
• Dyne Therapeutics' Interest Coverage Ratio stood at 0.35 in 2022, then tumbled by 31.42% to 0.46 in 2023, then slumped by 4098.65% to 19.5 in 2024, then plunged by 133.96% to 45.61 in 2025, then surged by 95.51% to 2.05 in 2026.
• Business Quant data shows DYN's Interest Coverage Ratio at 2.05 in Q2 2026, 2.54 in Q1 2026, and 45.61 in Q4 2025.